Seragen Biotherapeutics Private Limited, a active private limited company, was established on 20 July 2018 in Bengaluru, Karnataka, India. Engaging in ivf & maternity care centers within the hospital and medical care sector, it holds CIN: U24304KA2018PTC114941. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.12 M.
Its leadership includes Velmurugan Balasubramanian (Director), Shrinivas Rangachari (Director), Vasanthi Palanivel (Additional Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Helix Biotech Park, Ibab Campus, Electronic City Phase I,, Bengaluru, Karnataka, 560100.
U24304KA2018PTC114941
114941
20 July 2018
₹1.00 M
₹0.12 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Seragen Biotherapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Velmurugan Balasubramanian | Director | 20 Jul 2018 | Current |
| Shrinivas Rangachari | Director | 20 Jul 2018 | Current |
| Vasanthi Palanivel | Additional Director | 01 Jun 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Seragen Biotherapeutics Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 124.84% increase. The company also saw a substantial improvement in profitability, with a 427.36% increase in profit. The company's net worth Soared by an impressive increase of 20.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Seragen Biotherapeutics had a public holding of 52.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Seragen Biotherapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Seragen Biotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seragen Biotherapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Seragen Biotherapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Seragen Biotherapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Vasanthi Palanivel was appointed as a Additional Director was appointed as a Additional Director on 01 Jun 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
Progress on Velmurugan Balasubramanian was appointed as a Director was appointed as a Director on 20 Jul 2018 & has been associated with this company since 7 years 5 months . was documented.
The activity Shrinivas Rangachari was appointed as a Director was appointed as a Director on 20 Jul 2018 & has been associated with this company since 7 years 5 months . was completed.
Seragen Biotherapeutics Private Limited was registered on 20 Jul 2018 with Roc Bangalore & aged 7 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Seragen Biotherapeutics Private Limited is U24304KA2018PTC114941.
Seragen Biotherapeutics Private Limited is headquartered at Helix Biotech Park, Ibab Campus, Electronic City Phase I,, Bengaluru, Karnataka, 560100.
Seragen Biotherapeutics Private Limited was incorporated on 20 July 2018.
The current directors of Seragen Biotherapeutics Private Limited are
The primary industry of Seragen Biotherapeutics Private Limited is Hospital And Medical Care.
Seragen Biotherapeutics Private Limited is unlisted.
The authorized capital of Seragen Biotherapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.12 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX